Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
Maxime Rémond, Anna Pellat, Catherine Brézault, et al.
ESMO Open (2022) Vol. 7, Iss. 6, pp. 100638-100638
Open Access | Times Cited: 17

Showing 17 citing articles:

Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, et al.
Current Oncology (2023) Vol. 30, Iss. 4, pp. 3871-3885
Open Access | Times Cited: 18
The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
Ahmed A. Ahmed, William Greenhalf, Daniel H. Palmer, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2452-2452
Open Access | Times Cited: 17
Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer
Yuanxin Yao, Honghui Lv, M Zhang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 721-734
Closed Access | Times Cited: 4
In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation
Marco Notaro, Marco Borghetti, Chiara Bresesti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Challenges in diagnosing and treating distal common bile duct adenocarcinoma: A case report with literature insights
Sakhr Alshwayyat, Hamdah Hanifa, Yamen Alshwaiyat, et al.
International Journal of Emergency Medicine (2025) Vol. 18, Iss. 1
Open Access
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations
Thuy Phan, Darrell Fan, Laleh G. Melstrom
Current Oncology (2024) Vol. 31, Iss. 9, pp. 4855-4884
Open Access | Times Cited: 2
The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer
Ioannis A. Voutsadakis, Antonia Digklia
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2105-2120
Open Access | Times Cited: 5
Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer
Brandon G. Smaglo
Cancers (2023) Vol. 15, Iss. 8, pp. 2377-2377
Open Access | Times Cited: 5
Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?
Shiao Li Oei, Friedemann Schad
Cancers (2023) Vol. 15, Iss. 4, pp. 1116-1116
Open Access | Times Cited: 3
Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, et al.
Advances in cancer research (2023), pp. 113-143
Closed Access | Times Cited: 3
Coronin 1C, Regulated by Multiple microRNAs, Facilitates Cancer Cell Aggressiveness in Pancreatic Ductal Adenocarcinoma
Kosuke Fukuda, Naohiko Seki, Ryutaro Yasudome, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 995-995
Open Access | Times Cited: 2
Conditions for Effective Use of Liposomal Irinotecan with Fluorouracil and Leucovorin in Unresectable Pancreatic Cancer After FOLFIRINOX Treatment
Yasuyuki Okada, Yasushi Sato, Ryo Shinomiya, et al.
Research Square (Research Square) (2024)
Closed Access
A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review
Andreea Ilieşiu, Radu-Valeriu Toma, Ana Ciongariu, et al.
Oncology Letters (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 1
Crosstalk of nervous and immune systems in pancreatic cancer
Feifei Huang, Wenhui Cui, Lan-Yue Ma, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 1
Pancreatic Ductal Adenocarcinoma: Current and Emerging Treatments
Elizabeth A. Baker, Harry Craft
Journal of Student Research (2023) Vol. 12, Iss. 3
Open Access
Cancers digestifs
Jacques Robert
Elsevier eBooks (2023), pp. 199-205
Closed Access
Page 1

Scroll to top